|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.510 USD | -5.65% |
|
-2.45% | - |
| 07-02 | Cosmos Health Expands Share Buyback to 3.4 Million Shares | MT |
| 06-30 | Cosmos Health Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
| Market Cap | 12.88M 11.27M 10.35M 9.65M 18.3M 1.23B 18.58M 124M 48.32M 603M 48.36M 47.32M 2.08B | P/E 2026 * |
23.7x | P/E 2027 * | 3.39x |
|---|---|---|---|---|---|
| Enterprise Value | 12.88M 11.27M 10.35M 9.65M 18.3M 1.23B 18.58M 124M 48.32M 603M 48.36M 47.32M 2.08B | EV / Sales 2026 * |
0.15x | EV / Sales 2027 * | 0.12x |
| Free-Float |
65.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Grigorios Siokas
CEO | Chief Executive Officer | 60 | 2016-02-25 |
George Terzis
DFI | Director of Finance/CFO | 44 | 2020-11-10 |
| Chief Operating Officer | - | 2023-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2014-01-12 | |
Grigorios Siokas
CHM | Chairman | 60 | 2016-02-25 |
John Hoidas
BRD | Director/Board Member | 60 | 2016-11-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.65% | -2.45% | - | - | 12.88M | ||
| +2.37% | +2.98% | +9.31% | +86.86% | 92.06B | ||
| +0.51% | +0.43% | +44.87% | +152.61% | 55.96B | ||
| +2.20% | +0.72% | -7.31% | +236.14% | 22.26B | ||
| +1.26% | +5.43% | -10.09% | -24.81% | 8B | ||
| +1.90% | +13.78% | -26.29% | -30.76% | 7.76B | ||
| +1.89% | +6.02% | -9.61% | -30.25% | 6.66B | ||
| -2.66% | +2.67% | +21.60% | +33.33% | 6.35B | ||
| +0.17% | +0.88% | -2.65% | +21.18% | 5.36B | ||
| +1.86% | +6.93% | -5.00% | -8.21% | 3.63B | ||
| Average | +0.38% | +2.75% | +1.65% | +48.45% | 23.12B | |
| Weighted average by Cap. | +1.56% | +2.45% | +14.24% | +103.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 87.3M 76.34M 70.15M 65.39M 124M 8.31B 126M 837M 327M 4.08B 328M 321M 14.09B | 111M 96.89M 89.04M 82.99M 157M 10.55B 160M 1.06B 415M 5.18B 416M 407M 17.88B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COSM Stock
- COSM Stock
Select your edition
All financial news and data tailored to specific country editions
















